In RVHD patients the prevalence of risk factors (hypertension, dyslipidaemia, diabetes), cardiac abnormalities (ejection fraction and regional wall abnormalities), inflammatory markers (WBC, monocytes, neutrophils and NLR), hepatic functional (ALT, AST, GGT, and bilirubin) and renal markers (creatinine, BUN, and calcium) were all significantly lower compared to the patients with coexisting CAD, except for albumin levels. The gene discussed is GPT; the disease is diabetes mellitus.